Effect of Sodium Glucose Transporter-2 (SGLT-2) Inhibitors on Liver Fibrosis in Patients With Type2 Diabetes and Chronic Liver Disease (F3 Fibrosis) Using Liver Fibroscan
Condition: Type2diabetes Intervention: Sponsors: Diabetes Foundation, India; National Diabetes Obesity and Cholesterol Foundation Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cholesterol | Diabetes | Eating Disorders & Weight Management | Endocrinology | India Health | Liver | Liver Disease | Obesity | Research | Sodium | Urology & Nephrology